Fungal infections in immunocompromised patients. - Wikidata - wikimedia - TriplyDB

Fungal infections in immunocompromised patients.

Fungal infections in immunocompromised patients.

http://www.wikidata.org/entity/Q44620717

about

Potent and Synergistic Extract Combinations from Terminalia Catappa, Terminalia Mantaly and Monodora tenuifolia Against Pathogenic Yeasts.Touch preparation for the rapid diagnosis of disseminated aspergillosis.

P2860

Q41748035-106AAB37-6A24-45C6-8147-85A16135AEE7 Q42291224-9F01261B-826A-474E-9F05-CF67C1CD5389

P2860

Fungal infections in immunocompromised patients.

http://www.wikidata.org/entity/Q44620717

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Fungal infections in immunocompromised patients.

@en

Fungal infections in immunocompromised patients.

@nl

type

label

Fungal infections in immunocompromised patients.

@en

Fungal infections in immunocompromised patients.

@nl

prefLabel

Fungal infections in immunocompromised patients.

@en

Fungal infections in immunocompromised patients.

@nl

P1433

Q44620717-6C98CE6D-F274-442B-AE8D-7B3B38485BA5

P1476

Q44620717-245CDB05-5A66-498E-A9DF-AEC922F161EF

P2093

Q44620717-DF434D08-B84D-40D4-94EB-0506283742E2

P2860

Q44620717-1265AC9C-5E23-4990-91C9-853244B1ED35

Q44620717-29336DF2-9B36-4214-BC48-B873D4C92A4D

Q44620717-4010D670-EB4E-4FDA-ABFA-FDA3E49848EE

Q44620717-52467316-63F0-46A8-A394-13C3B3C6914C

Q44620717-7FD54504-8C7A-488E-A882-8B77300B8089

Q44620717-82400D91-98B7-4D68-AA3C-D808264B2B45

Q44620717-8827E617-16ED-4059-A610-8C32E169EF76

Q44620717-887FA043-F623-49DC-8C1A-C98FB9AB8471

Q44620717-9032FBB4-0D6E-4A97-B30D-B930338D7302

Q44620717-A80FC961-B3CC-40D0-9D2A-6C0F40B5C8B7

P304

Q44620717-E6A13CA3-9191-4240-BE46-75EA100AF6D2

P31

Q44620717-CC7415C8-951C-4DBB-9721-CD2941B7C13D

P356

Q44620717-6F5267D3-A3E9-478E-8336-E420F9D9D9E3

P478

Q44620717-E508A662-43C0-4063-B93E-D8CFF6E16017

P577

Q44620717-D14397B6-0148-4370-8682-B53958DF5FD2

P5875

Q44620717-5BA30926-DB16-4460-BE78-86A41DC78BE8

P698

Q44620717-367DB2F2-724A-4276-A577-9ED9071A4CC5

P356

J.1439-0507.2011.02134.X

P1433

P1476

Fungal infections in immunocompromised patients.

@en

P2093

Gabriele Sganga

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

Invasive aspergillosis in the intensive care unit

Assessing risk factors for systemic fungal infections.

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Update on the laboratory diagnosis of invasive fungal infections

Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.

Anidulafungin: review of a new echinocandin antifungal agent.

Anidulafungin: a novel echinocandin.

Early diagnosis of fungal infection in immunocompromised patients.

Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment.

P304

1-3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1439-0507.2011.02134.X

http://www.w3.org/2001/XMLSchema#string

P478

54 Suppl 4

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221718221

http://www.w3.org/2001/XMLSchema#string

P698

22126521

http://www.w3.org/2001/XMLSchema#string